Loading…

Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins

Cervical cancer is the most common gynecological malignancy in the world; however, the survival rates of advanced-stage and recurrent cervical cancer patients remain poor. The multifaced protein insulin-like growth factor 2 receptor (IGF2R) has various ligands, represented as IGF-2 and mannose-6-pho...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2019-11, Vol.10 (12), p.876-17, Article 876
Main Authors: Takeda, Takashi, Komatsu, Masayuki, Chiwaki, Fumiko, Komatsuzaki, Rie, Nakamura, Kanako, Tsuji, Kosuke, Kobayashi, Yusuke, Tominaga, Eiichiro, Ono, Masaya, Banno, Kouji, Aoki, Daisuke, Sasaki, Hiroki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63
cites cdi_FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63
container_end_page 17
container_issue 12
container_start_page 876
container_title Cell death & disease
container_volume 10
creator Takeda, Takashi
Komatsu, Masayuki
Chiwaki, Fumiko
Komatsuzaki, Rie
Nakamura, Kanako
Tsuji, Kosuke
Kobayashi, Yusuke
Tominaga, Eiichiro
Ono, Masaya
Banno, Kouji
Aoki, Daisuke
Sasaki, Hiroki
description Cervical cancer is the most common gynecological malignancy in the world; however, the survival rates of advanced-stage and recurrent cervical cancer patients remain poor. The multifaced protein insulin-like growth factor 2 receptor (IGF2R) has various ligands, represented as IGF-2 and mannose-6-phosphate (M6P)-tagged proteins. Regarding its antagonistic activity as an IGF1R signal, IGF2R is currently considered a tumor suppressor gene, whereas its significance as an M6P receptor is still unclear. Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. Several experiments using cervical cancer cell lines revealed that IGF2R depletion induced apoptosis, decreased cell viability, and increased vulnerability to certain anticancer drug cisplatin. In contrast to its negligible impact in IGF1R signaling, loss of IGF2R disrupted the Golgi-to-lysosome transport of M6P-tagged cathepsins, resulting in decreased lysosomal activity, with their abnormal accumulation and dysfunction of both autophagy and mitophagy, which cause the accumulation of misfolded proteins and production of reactive oxygen species. Taken together, IGF2R has an oncogenic role through transportation of M6P-tagged cargo in cervical cancer and can be used as a predictive biomarker for prognostic classification.
doi_str_mv 10.1038/s41419-019-2117-9
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6868013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2316416489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVIacI2P6CXYOglF7eSZcvypVBCkgYChdKcxVgfGwWv5Grshf33kbNJmgYiJDRinhnNy0vIZ0a_MsrlN6xZzbqS5lMx1pbdATmuaM3KWsru8FV8RE4Q72lenNOqER_JEWdtLRtKj8nudkx2PQ8w-RiK6Irrq8vqd2G3YCwWww4jxg0Mhdmhm4NeqNIHM2trChjjOEX0uNRpm7ZeZ1JDyHF-DwMWWw_FlCDgGNP0iMF0Z0f0AT-RDw4GtCdP94rcXl78Of9Z3vy6uj7_cVPqhoupFFXXQuUa2fGWGy6dlEZrELXtnYVGmE64nmom-p43VEAODeNG9kCZdiD4inzf9x3nfmONtiEPNKgx-Q2knYrg1f-Z4O_UOm6VkEJSxnODs6cGKf6dLU5q43GRB8HGGVXFmWgll3RBv7xB7-OcQpb3SNV5Zx0rwvaUThExWfcyDKNq8VbtvVXZW7V4q5aa09cqXiqencxAtQcwp8Lapn9fv9_1AWutsjc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2316416489</pqid></control><display><type>article</type><title>Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Takeda, Takashi ; Komatsu, Masayuki ; Chiwaki, Fumiko ; Komatsuzaki, Rie ; Nakamura, Kanako ; Tsuji, Kosuke ; Kobayashi, Yusuke ; Tominaga, Eiichiro ; Ono, Masaya ; Banno, Kouji ; Aoki, Daisuke ; Sasaki, Hiroki</creator><creatorcontrib>Takeda, Takashi ; Komatsu, Masayuki ; Chiwaki, Fumiko ; Komatsuzaki, Rie ; Nakamura, Kanako ; Tsuji, Kosuke ; Kobayashi, Yusuke ; Tominaga, Eiichiro ; Ono, Masaya ; Banno, Kouji ; Aoki, Daisuke ; Sasaki, Hiroki</creatorcontrib><description>Cervical cancer is the most common gynecological malignancy in the world; however, the survival rates of advanced-stage and recurrent cervical cancer patients remain poor. The multifaced protein insulin-like growth factor 2 receptor (IGF2R) has various ligands, represented as IGF-2 and mannose-6-phosphate (M6P)-tagged proteins. Regarding its antagonistic activity as an IGF1R signal, IGF2R is currently considered a tumor suppressor gene, whereas its significance as an M6P receptor is still unclear. Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. Several experiments using cervical cancer cell lines revealed that IGF2R depletion induced apoptosis, decreased cell viability, and increased vulnerability to certain anticancer drug cisplatin. In contrast to its negligible impact in IGF1R signaling, loss of IGF2R disrupted the Golgi-to-lysosome transport of M6P-tagged cathepsins, resulting in decreased lysosomal activity, with their abnormal accumulation and dysfunction of both autophagy and mitophagy, which cause the accumulation of misfolded proteins and production of reactive oxygen species. Taken together, IGF2R has an oncogenic role through transportation of M6P-tagged cargo in cervical cancer and can be used as a predictive biomarker for prognostic classification.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-019-2117-9</identifier><identifier>PMID: 31748500</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/109 ; 13/2 ; 13/31 ; 13/44 ; 13/89 ; 14 ; 14/63 ; 38/39 ; 631/67/1059/602 ; 631/67/1517/1371 ; 631/80/82/23 ; 82/1 ; 96/95 ; Antibodies ; Apoptosis ; Apoptosis - physiology ; Autophagy ; Biochemistry ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Biomedical and Life Sciences ; Cathepsins ; Cathepsins - metabolism ; Cell Biology ; Cell Culture ; Cell viability ; Cervical cancer ; Cervix ; Cisplatin ; Female ; Gene expression ; Gene Knockdown Techniques ; Golgi apparatus ; Golgi Apparatus - genetics ; Golgi Apparatus - metabolism ; Golgi Apparatus - pathology ; Humans ; Immunology ; Insulin ; Insulin-like growth factor II receptors ; Life Sciences ; Lysosomes - genetics ; Lysosomes - metabolism ; Lysosomes - pathology ; Malignancy ; Mannose ; Medical prognosis ; Middle Aged ; Phagocytosis ; Protein folding ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Receptor, IGF Type 1 - metabolism ; Receptor, IGF Type 2 - metabolism ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Tumor cell lines ; Tumor suppressor genes ; Up-Regulation ; Uterine Cervical Neoplasms - genetics ; Uterine Cervical Neoplasms - metabolism ; Uterine Cervical Neoplasms - pathology</subject><ispartof>Cell death &amp; disease, 2019-11, Vol.10 (12), p.876-17, Article 876</ispartof><rights>The Author(s) 2019</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63</citedby><cites>FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63</cites><orcidid>0000-0001-6686-5742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2316416489/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2316416489?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31748500$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takeda, Takashi</creatorcontrib><creatorcontrib>Komatsu, Masayuki</creatorcontrib><creatorcontrib>Chiwaki, Fumiko</creatorcontrib><creatorcontrib>Komatsuzaki, Rie</creatorcontrib><creatorcontrib>Nakamura, Kanako</creatorcontrib><creatorcontrib>Tsuji, Kosuke</creatorcontrib><creatorcontrib>Kobayashi, Yusuke</creatorcontrib><creatorcontrib>Tominaga, Eiichiro</creatorcontrib><creatorcontrib>Ono, Masaya</creatorcontrib><creatorcontrib>Banno, Kouji</creatorcontrib><creatorcontrib>Aoki, Daisuke</creatorcontrib><creatorcontrib>Sasaki, Hiroki</creatorcontrib><title>Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins</title><title>Cell death &amp; disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>Cervical cancer is the most common gynecological malignancy in the world; however, the survival rates of advanced-stage and recurrent cervical cancer patients remain poor. The multifaced protein insulin-like growth factor 2 receptor (IGF2R) has various ligands, represented as IGF-2 and mannose-6-phosphate (M6P)-tagged proteins. Regarding its antagonistic activity as an IGF1R signal, IGF2R is currently considered a tumor suppressor gene, whereas its significance as an M6P receptor is still unclear. Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. Several experiments using cervical cancer cell lines revealed that IGF2R depletion induced apoptosis, decreased cell viability, and increased vulnerability to certain anticancer drug cisplatin. In contrast to its negligible impact in IGF1R signaling, loss of IGF2R disrupted the Golgi-to-lysosome transport of M6P-tagged cathepsins, resulting in decreased lysosomal activity, with their abnormal accumulation and dysfunction of both autophagy and mitophagy, which cause the accumulation of misfolded proteins and production of reactive oxygen species. Taken together, IGF2R has an oncogenic role through transportation of M6P-tagged cargo in cervical cancer and can be used as a predictive biomarker for prognostic classification.</description><subject>13/109</subject><subject>13/2</subject><subject>13/31</subject><subject>13/44</subject><subject>13/89</subject><subject>14</subject><subject>14/63</subject><subject>38/39</subject><subject>631/67/1059/602</subject><subject>631/67/1517/1371</subject><subject>631/80/82/23</subject><subject>82/1</subject><subject>96/95</subject><subject>Antibodies</subject><subject>Apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Autophagy</subject><subject>Biochemistry</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biomedical and Life Sciences</subject><subject>Cathepsins</subject><subject>Cathepsins - metabolism</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Cell viability</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Cisplatin</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Knockdown Techniques</subject><subject>Golgi apparatus</subject><subject>Golgi Apparatus - genetics</subject><subject>Golgi Apparatus - metabolism</subject><subject>Golgi Apparatus - pathology</subject><subject>Humans</subject><subject>Immunology</subject><subject>Insulin</subject><subject>Insulin-like growth factor II receptors</subject><subject>Life Sciences</subject><subject>Lysosomes - genetics</subject><subject>Lysosomes - metabolism</subject><subject>Lysosomes - pathology</subject><subject>Malignancy</subject><subject>Mannose</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Phagocytosis</subject><subject>Protein folding</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptor, IGF Type 1 - metabolism</subject><subject>Receptor, IGF Type 2 - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Tumor cell lines</subject><subject>Tumor suppressor genes</subject><subject>Up-Regulation</subject><subject>Uterine Cervical Neoplasms - genetics</subject><subject>Uterine Cervical Neoplasms - metabolism</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kU1r3DAQhkVIacI2P6CXYOglF7eSZcvypVBCkgYChdKcxVgfGwWv5Grshf33kbNJmgYiJDRinhnNy0vIZ0a_MsrlN6xZzbqS5lMx1pbdATmuaM3KWsru8FV8RE4Q72lenNOqER_JEWdtLRtKj8nudkx2PQ8w-RiK6Irrq8vqd2G3YCwWww4jxg0Mhdmhm4NeqNIHM2trChjjOEX0uNRpm7ZeZ1JDyHF-DwMWWw_FlCDgGNP0iMF0Z0f0AT-RDw4GtCdP94rcXl78Of9Z3vy6uj7_cVPqhoupFFXXQuUa2fGWGy6dlEZrELXtnYVGmE64nmom-p43VEAODeNG9kCZdiD4inzf9x3nfmONtiEPNKgx-Q2knYrg1f-Z4O_UOm6VkEJSxnODs6cGKf6dLU5q43GRB8HGGVXFmWgll3RBv7xB7-OcQpb3SNV5Zx0rwvaUThExWfcyDKNq8VbtvVXZW7V4q5aa09cqXiqencxAtQcwp8Lapn9fv9_1AWutsjc</recordid><startdate>20191120</startdate><enddate>20191120</enddate><creator>Takeda, Takashi</creator><creator>Komatsu, Masayuki</creator><creator>Chiwaki, Fumiko</creator><creator>Komatsuzaki, Rie</creator><creator>Nakamura, Kanako</creator><creator>Tsuji, Kosuke</creator><creator>Kobayashi, Yusuke</creator><creator>Tominaga, Eiichiro</creator><creator>Ono, Masaya</creator><creator>Banno, Kouji</creator><creator>Aoki, Daisuke</creator><creator>Sasaki, Hiroki</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6686-5742</orcidid></search><sort><creationdate>20191120</creationdate><title>Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins</title><author>Takeda, Takashi ; Komatsu, Masayuki ; Chiwaki, Fumiko ; Komatsuzaki, Rie ; Nakamura, Kanako ; Tsuji, Kosuke ; Kobayashi, Yusuke ; Tominaga, Eiichiro ; Ono, Masaya ; Banno, Kouji ; Aoki, Daisuke ; Sasaki, Hiroki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>13/109</topic><topic>13/2</topic><topic>13/31</topic><topic>13/44</topic><topic>13/89</topic><topic>14</topic><topic>14/63</topic><topic>38/39</topic><topic>631/67/1059/602</topic><topic>631/67/1517/1371</topic><topic>631/80/82/23</topic><topic>82/1</topic><topic>96/95</topic><topic>Antibodies</topic><topic>Apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Autophagy</topic><topic>Biochemistry</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biomedical and Life Sciences</topic><topic>Cathepsins</topic><topic>Cathepsins - metabolism</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Cell viability</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Cisplatin</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Knockdown Techniques</topic><topic>Golgi apparatus</topic><topic>Golgi Apparatus - genetics</topic><topic>Golgi Apparatus - metabolism</topic><topic>Golgi Apparatus - pathology</topic><topic>Humans</topic><topic>Immunology</topic><topic>Insulin</topic><topic>Insulin-like growth factor II receptors</topic><topic>Life Sciences</topic><topic>Lysosomes - genetics</topic><topic>Lysosomes - metabolism</topic><topic>Lysosomes - pathology</topic><topic>Malignancy</topic><topic>Mannose</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Phagocytosis</topic><topic>Protein folding</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptor, IGF Type 1 - metabolism</topic><topic>Receptor, IGF Type 2 - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Tumor cell lines</topic><topic>Tumor suppressor genes</topic><topic>Up-Regulation</topic><topic>Uterine Cervical Neoplasms - genetics</topic><topic>Uterine Cervical Neoplasms - metabolism</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeda, Takashi</creatorcontrib><creatorcontrib>Komatsu, Masayuki</creatorcontrib><creatorcontrib>Chiwaki, Fumiko</creatorcontrib><creatorcontrib>Komatsuzaki, Rie</creatorcontrib><creatorcontrib>Nakamura, Kanako</creatorcontrib><creatorcontrib>Tsuji, Kosuke</creatorcontrib><creatorcontrib>Kobayashi, Yusuke</creatorcontrib><creatorcontrib>Tominaga, Eiichiro</creatorcontrib><creatorcontrib>Ono, Masaya</creatorcontrib><creatorcontrib>Banno, Kouji</creatorcontrib><creatorcontrib>Aoki, Daisuke</creatorcontrib><creatorcontrib>Sasaki, Hiroki</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell death &amp; disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeda, Takashi</au><au>Komatsu, Masayuki</au><au>Chiwaki, Fumiko</au><au>Komatsuzaki, Rie</au><au>Nakamura, Kanako</au><au>Tsuji, Kosuke</au><au>Kobayashi, Yusuke</au><au>Tominaga, Eiichiro</au><au>Ono, Masaya</au><au>Banno, Kouji</au><au>Aoki, Daisuke</au><au>Sasaki, Hiroki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins</atitle><jtitle>Cell death &amp; disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2019-11-20</date><risdate>2019</risdate><volume>10</volume><issue>12</issue><spage>876</spage><epage>17</epage><pages>876-17</pages><artnum>876</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>Cervical cancer is the most common gynecological malignancy in the world; however, the survival rates of advanced-stage and recurrent cervical cancer patients remain poor. The multifaced protein insulin-like growth factor 2 receptor (IGF2R) has various ligands, represented as IGF-2 and mannose-6-phosphate (M6P)-tagged proteins. Regarding its antagonistic activity as an IGF1R signal, IGF2R is currently considered a tumor suppressor gene, whereas its significance as an M6P receptor is still unclear. Here, on the basis of transcriptome analysis of TCGA and GEO open datasets, we show that IGF2R is upregulated and correlated with poor prognosis in cervical cancer. Several experiments using cervical cancer cell lines revealed that IGF2R depletion induced apoptosis, decreased cell viability, and increased vulnerability to certain anticancer drug cisplatin. In contrast to its negligible impact in IGF1R signaling, loss of IGF2R disrupted the Golgi-to-lysosome transport of M6P-tagged cathepsins, resulting in decreased lysosomal activity, with their abnormal accumulation and dysfunction of both autophagy and mitophagy, which cause the accumulation of misfolded proteins and production of reactive oxygen species. Taken together, IGF2R has an oncogenic role through transportation of M6P-tagged cargo in cervical cancer and can be used as a predictive biomarker for prognostic classification.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31748500</pmid><doi>10.1038/s41419-019-2117-9</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-6686-5742</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-4889
ispartof Cell death & disease, 2019-11, Vol.10 (12), p.876-17, Article 876
issn 2041-4889
2041-4889
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6868013
source Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/109
13/2
13/31
13/44
13/89
14
14/63
38/39
631/67/1059/602
631/67/1517/1371
631/80/82/23
82/1
96/95
Antibodies
Apoptosis
Apoptosis - physiology
Autophagy
Biochemistry
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Biomedical and Life Sciences
Cathepsins
Cathepsins - metabolism
Cell Biology
Cell Culture
Cell viability
Cervical cancer
Cervix
Cisplatin
Female
Gene expression
Gene Knockdown Techniques
Golgi apparatus
Golgi Apparatus - genetics
Golgi Apparatus - metabolism
Golgi Apparatus - pathology
Humans
Immunology
Insulin
Insulin-like growth factor II receptors
Life Sciences
Lysosomes - genetics
Lysosomes - metabolism
Lysosomes - pathology
Malignancy
Mannose
Medical prognosis
Middle Aged
Phagocytosis
Protein folding
Reactive oxygen species
Reactive Oxygen Species - metabolism
Receptor, IGF Type 1 - metabolism
Receptor, IGF Type 2 - metabolism
RNA, Messenger - genetics
RNA, Messenger - metabolism
Tumor cell lines
Tumor suppressor genes
Up-Regulation
Uterine Cervical Neoplasms - genetics
Uterine Cervical Neoplasms - metabolism
Uterine Cervical Neoplasms - pathology
title Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A20%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulation%20of%20IGF2R%20evades%20lysosomal%20dysfunction-induced%20apoptosis%20of%20cervical%20cancer%20cells%20via%20transport%20of%20cathepsins&rft.jtitle=Cell%20death%20&%20disease&rft.au=Takeda,%20Takashi&rft.date=2019-11-20&rft.volume=10&rft.issue=12&rft.spage=876&rft.epage=17&rft.pages=876-17&rft.artnum=876&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-019-2117-9&rft_dat=%3Cproquest_pubme%3E2316416489%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c536t-6297a2f589373d38f88dcca64ebfea56d96fb0c16bb3506a0c1d13d8ba01cfa63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2316416489&rft_id=info:pmid/31748500&rfr_iscdi=true